Figure 1 | Scientific Reports

Figure 1

From: Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers

Figure 1

SchB treatments affect hepatic and plasma TG levels in mouse models.

Schisandrin B (SchB) (A–B) the fruits of Schisandra chinensis; (C) SchB structure; (D) chromatogram of SchB in UHPLC analysis. (E) Plasma triglyceride (TG) and (F) hepatic TG in fasting group. (G) Plasma TG and (H) hepatic TG in non-fasting group. (I) Hepatic TG and (J) plasma TG in HFD-fed group. (K) Representative pictures show the Oil Red O staining of liver sections in HFD-fed mice. nf-veh: non-fasting vehicle control group; nf-SchB: non-fasting SchB-treated group; f-veh: fasting vehicle control group; f-SchB: fasting SchB-treated group; HFD-veh: HFD-fed vehicle control group; HFD-SchB: HFD-fed SchB-treated group. Shown is the mean ± SE (n = 10 mice in each group), *p < 0.05, **p < 0.01.

Back to article page